FOXA1: a Promising Prognostic Marker in Breast Cancer

被引：29
|
作者：
Hu, Qing [1 ]
Luo, Zhou [3 ]
Xu, Tao [3 ]
Zhang, Jun-Ying [2 ]
Zhu, Ying [3 ]
Chen, Wei-Xian [3 ]
Zhong, Shan-Liang [4 ]
Zhao, Jian-Hua [4 ]
Tang, Jin-Hai [5 ]
机构：
[1] Xuzhou Med Coll, Dept Gen Surg, Xuzhou, Peoples R China
[2] Xuzhou Med Coll, Dept Oncol, Xuzhou, Peoples R China
[3] Nanjing Med Univ, Dept Oncol, Nanjing, Jiangsu, Peoples R China
[4] Jiangsu Canc Hosp, Clin Lab Ctr, Nanjing, Jiangsu, Peoples R China
[5] Jiangsu Canc Hosp, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China
来源：
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION | 2014年 / 15卷 / 01期
关键词：
FOXA1; prognosis; biomarker; breast cancer; systematic review; EXPRESSION; GENE; DETERMINANT; TARGET; GATA-3; TUMORS; BOX;
D O I：
10.7314/APJCP.2014.15.1.11
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Accurate diagnosis and proper monitoring of cancer patients remain important obstacles for successful cancer treatment. The search for cancer biomarkers can aid in more accurate prediction of clinical outcome and may also reveal novel predictive factors and therapeutic targets. One such prognostic marker seems to be FOXA1. Many studies have shown that FOXA1 is strongly expressed in a vast majority of cancers, including breast cancer, in which high expression is associated with a good prognosis. In this review, we summarize the role of this transcription factor in the development and prognosis of breast cancer in the hope of providing insights into utility of FOXA1 as a novel biomarker.
引用
收藏
页码：11 / 16
页数：6
相关论文
共 50 条
  • [1] FOXA1 in Breast Cancer: A Luminal Marker with Promising Prognostic and Predictive Impact
    Metovic, Jasna
    Borella, Fulvio
    D'Alonzo, Marta
    Biglia, Nicoletta
    Mangherini, Luca
    Tampieri, Cristian
    Bertero, Luca
    Cassoni, Paola
    Castellano, Isabella
    [J]. CANCERS, 2022, 14 (19)
  • [2] FOXA1: A prognostic and luminal subtype a marker in breast cancer
    Marchio, C.
    Thorat, M.
    Morimiya, A.
    Savage, K.
    Nakshatri, H.
    Reis-Filho, J.
    Badve, S.
    [J]. LABORATORY INVESTIGATION, 2008, 88 : 45A - 45A
  • [3] FOXA1: A prognostic and luminal subtype a marker in breast cancer
    Marchio, C.
    Thorat, M.
    Morimiya, A.
    Savage, K.
    Nakshatri, H.
    Reis-Filho, J.
    Badve, S.
    [J]. MODERN PATHOLOGY, 2008, 21 : 45A - 45A
  • [4] FOXA1 Is a Prognostic Marker in Breast Cancer - A Validation Study of 4046 Cases
    Mehta, R.
    Jain, R. K.
    Nielsen, T. O.
    Leung, S.
    Choo, J.
    Nakshatri, H.
    Hunstman, D.
    Badve, S.
    [J]. LABORATORY INVESTIGATION, 2010, 90 : 62A - 62A
  • [5] FOXA1 Is a Prognostic Marker in Breast Cancer - A Validation Study of 4046 Cases
    Mehta, R.
    Jain, R. K.
    Nielsen, T. O.
    Leung, S.
    Choo, J.
    Nakshatri, H.
    Hunstman, D.
    Badve, S.
    [J]. MODERN PATHOLOGY, 2010, 23 : 62A - 62A
  • [6] FOXA1 is an independent prognostic marker for ER-positive breast cancer
    Rutika J. Mehta
    Rohit K. Jain
    Samuel Leung
    Jennifer Choo
    Torsten Nielsen
    David Huntsman
    Harikrishna Nakshatri
    Sunil Badve
    [J]. Breast Cancer Research and Treatment, 2012, 131 : 881 - 890
  • [7] FOXA1 is an independent prognostic marker for ER-positive breast cancer
    Mehta, Rutika J.
    Jain, Rohit K.
    Leung, Samuel
    Choo, Jennifer
    Nielsen, Torsten
    Huntsman, David
    Nakshatri, Harikrishna
    Badve, Sunil
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (03) : 881 - 890
  • [8] FOXA1 in breast cancer
    Nakshatri, Harikrishna
    Badve, Sunil
    [J]. EXPERT REVIEWS IN MOLECULAR MEDICINE, 2009, 11
  • [9] FOXA1 a Poor Prognostic Marker in Prostate Cancer: A Validation Study
    Jain, R. K.
    Mehta, R.
    Ro, J.
    Nakshatri, H.
    Cho, Y. M.
    Badve, S.
    [J]. LABORATORY INVESTIGATION, 2011, 91 : 200A - 200A
  • [10] FOXA1 a Poor Prognostic Marker in Prostate Cancer: A Validation Study
    Jain, R. K.
    Mehta, R.
    Ro, J.
    Nakshatri, H.
    Cho, Y. M.
    Badve, S.
    [J]. MODERN PATHOLOGY, 2011, 24 : 200A - 200A
12345